Journal of Comparative Effectiveness Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data
Conclusion: Despite utilization of current treatments for MG, MG exacerbations are associated with a high clinical and economic burden in both commercial and Medicare patients. Additional treatment options and improved disease management may help to reduce exacerbations and disease burden.PMID:38099519 | DOI:10.57264/cer-2023-0108 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Julia Pisc Angela Ting Michelle Skornicki Omar Sinno Edward Lee Source Type: research
Treatment patterns and economic burden of bacterial vaginosis among commercially insured women in the USA
Conclusion: BV recurrence among this population represented a substantial clinical and healthcare economic burden warranting improvements in women's healthcare.PMID:38099520 | DOI:10.57264/cer-2023-0079 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Eren Watkins Clifton M Chow Melissa Lingohr-Smith Jay Lin Candice Yong Krishna Tangirala Kevin Collins James Li Roy Brooks Jennifer Amico Source Type: research
Improved estimation of overall survival and progression-free survival for state transition modeling
Conclusion: A novel approach is defined which provides an alternative STM estimation method enabling improved fits to modeled endpoints, which can easily be extended to more complex model structures.PMID:38099516 | DOI:10.57264/cer-2023-0031 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Peter C Wigfield Bart Heeg Mario Ouwens Source Type: research
Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting
Conclusion: In the first R/R setting, patients who used InO had significantly lower all-cause and ALL-related costs compared with patients who used Blina, in part driven by hospitalization patterns.PMID:38099517 | DOI:10.57264/cer-2023-0142 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Alexander Russell-Smith Louise Murphy Amy Nguyen Cori Blauer-Peterson Marilou Terpenning Feng Cao Shiqiang Li Tim Bancroft Noah Webb Stephanie Dorman Richa Shah Source Type: research
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis
Conclusion: The 20% lower risk of LTCA (i.e., greater delay) with PIM versus QUE in this analysis may suggest that PIM should be started early for the treatment of PDP.PMID:38099518 | DOI:10.57264/cer-2023-0114 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Krithika Rajagopalan Nazia Rashid Dilesh Doshi Source Type: research
Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data
Conclusion: Despite utilization of current treatments for MG, MG exacerbations are associated with a high clinical and economic burden in both commercial and Medicare patients. Additional treatment options and improved disease management may help to reduce exacerbations and disease burden.PMID:38099519 | DOI:10.57264/cer-2023-0108 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Julia Pisc Angela Ting Michelle Skornicki Omar Sinno Edward Lee Source Type: research
Treatment patterns and economic burden of bacterial vaginosis among commercially insured women in the USA
Conclusion: BV recurrence among this population represented a substantial clinical and healthcare economic burden warranting improvements in women's healthcare.PMID:38099520 | DOI:10.57264/cer-2023-0079 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Eren Watkins Clifton M Chow Melissa Lingohr-Smith Jay Lin Candice Yong Krishna Tangirala Kevin Collins James Li Roy Brooks Jennifer Amico Source Type: research
Improved estimation of overall survival and progression-free survival for state transition modeling
Conclusion: A novel approach is defined which provides an alternative STM estimation method enabling improved fits to modeled endpoints, which can easily be extended to more complex model structures.PMID:38099516 | DOI:10.57264/cer-2023-0031 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Peter C Wigfield Bart Heeg Mario Ouwens Source Type: research
Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting
Conclusion: In the first R/R setting, patients who used InO had significantly lower all-cause and ALL-related costs compared with patients who used Blina, in part driven by hospitalization patterns.PMID:38099517 | DOI:10.57264/cer-2023-0142 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Alexander Russell-Smith Louise Murphy Amy Nguyen Cori Blauer-Peterson Marilou Terpenning Feng Cao Shiqiang Li Tim Bancroft Noah Webb Stephanie Dorman Richa Shah Source Type: research
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis
Conclusion: The 20% lower risk of LTCA (i.e., greater delay) with PIM versus QUE in this analysis may suggest that PIM should be started early for the treatment of PDP.PMID:38099518 | DOI:10.57264/cer-2023-0114 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Krithika Rajagopalan Nazia Rashid Dilesh Doshi Source Type: research
Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data
Conclusion: Despite utilization of current treatments for MG, MG exacerbations are associated with a high clinical and economic burden in both commercial and Medicare patients. Additional treatment options and improved disease management may help to reduce exacerbations and disease burden.PMID:38099519 | DOI:10.57264/cer-2023-0108 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Julia Pisc Angela Ting Michelle Skornicki Omar Sinno Edward Lee Source Type: research
Treatment patterns and economic burden of bacterial vaginosis among commercially insured women in the USA
Conclusion: BV recurrence among this population represented a substantial clinical and healthcare economic burden warranting improvements in women's healthcare.PMID:38099520 | DOI:10.57264/cer-2023-0079 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Eren Watkins Clifton M Chow Melissa Lingohr-Smith Jay Lin Candice Yong Krishna Tangirala Kevin Collins James Li Roy Brooks Jennifer Amico Source Type: research
Improved estimation of overall survival and progression-free survival for state transition modeling
Conclusion: A novel approach is defined which provides an alternative STM estimation method enabling improved fits to modeled endpoints, which can easily be extended to more complex model structures.PMID:38099516 | DOI:10.57264/cer-2023-0031 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Peter C Wigfield Bart Heeg Mario Ouwens Source Type: research
Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting
Conclusion: In the first R/R setting, patients who used InO had significantly lower all-cause and ALL-related costs compared with patients who used Blina, in part driven by hospitalization patterns.PMID:38099517 | DOI:10.57264/cer-2023-0142 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Alexander Russell-Smith Louise Murphy Amy Nguyen Cori Blauer-Peterson Marilou Terpenning Feng Cao Shiqiang Li Tim Bancroft Noah Webb Stephanie Dorman Richa Shah Source Type: research
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis
Conclusion: The 20% lower risk of LTCA (i.e., greater delay) with PIM versus QUE in this analysis may suggest that PIM should be started early for the treatment of PDP.PMID:38099518 | DOI:10.57264/cer-2023-0114 (Source: Journal of Comparative Effectiveness Research)
Source: Journal of Comparative Effectiveness Research - December 15, 2023 Category: General Medicine Authors: Krithika Rajagopalan Nazia Rashid Dilesh Doshi Source Type: research